Related Experiment Video
Updated: Jun 5, 2026

Measurements of Physiological Stress Responses in C. Elegans
Published on: May 21, 2020
Molecular mechanisms of the Keap1–Nrf2 pathway in stress response and cancer evolution
Keiko Taguchi1, Hozumi Motohashi, Masayuki Yamamoto
1Department of Medical Biochemistry, Tohoku University Graduate School of Medicine, 2-1 Seiryo-cho, Aoba-ku, Sendai 980-8575, Japan.
Abstract:
The Keap1–Nrf2 regulatory pathway plays a central role in the protection of cells against oxidative and xenobiotic damage. Under unstressed conditions, Nrf2 is constantly ubiquitinated by the Cul3–Keap1 ubiquitin E3 ligase complex and rapidly degraded in proteasomes. Upon exposure to electrophilic and oxidative stresses, reactive cysteine residues of Keap1 become modified, leading to a decline in the E3 ligase activity, stabilization of Nrf2 and robust induction of a battery of cytoprotective genes. Biochemical and structural analyses have revealed that the intact Keap1 homodimer forms a cherry-bob structure in which one molecule of Nrf2 associates with two molecules of Keap1 by using two binding sites within the Neh2 domain of Nrf2. This two-site binding appears critical for Nrf2 ubiquitination. In many human cancers, missense mutations in KEAP1 and NRF2 genes have been identified. These mutations disrupt the Keap1–Nrf2 complex activity involved in ubiquitination and degradation of Nrf2 and result in constitutive activation of Nrf2. Elevated expression of Nrf2 target genes confers advantages in terms of stress resistance and cell proliferation in normal and cancer cells. Discovery and development of selective Nrf2 inhibitors should make a critical contribution to improved cancer therapy.
Insights
The Keap1–Nrf2 pathway protects cells from damage. Mutations in Keap1 and Nrf2 genes lead to cancer cell proliferation, suggesting Nrf2 inhibitors could be effective cancer therapies.
Area of Science:
- Cellular biology
- Molecular mechanisms of cell protection
- Cancer research
Background:
- The Keap1–Nrf2 pathway is crucial for cellular defense against oxidative and xenobiotic stress.
- Under normal conditions, Nrf2 is ubiquitinated by the Cul3–Keap1 E3 ligase complex and degraded.
- Stress triggers Keap1 modification, stabilizing Nrf2 and inducing protective genes.
Purpose of the Study:
- To elucidate the structural basis of Keap1–Nrf2 interaction and its role in ubiquitination.
- To investigate the impact of KEAP1 and NRF2 mutations in human cancers.
- To explore the therapeutic potential of targeting the Keap1–Nrf2 pathway in cancer.
Main Methods:
- Biochemical analyses of the Keap1–Nrf2 complex.
- Structural studies of the Keap1–Nrf2 interaction.
- Analysis of genetic mutations in KEAP1 and NRF2 in cancer patient data.
Main Results:
- The Keap1 homodimer binds Nrf2 via two sites on Nrf2's Neh2 domain, critical for ubiquitination.
- Missense mutations in KEAP1 and NRF2 are common in human cancers.
- These mutations disrupt Keap1–Nrf2 complex function, leading to constitutive Nrf2 activation.
Conclusions:
- The Keap1–Nrf2 interaction is essential for regulating Nrf2 stability and cellular defense.
- Aberrant Nrf2 activation due to genetic mutations promotes cancer cell survival and proliferation.
- Targeting Nrf2 inhibition presents a promising strategy for cancer treatment.
Related Concept Videos
Regulation of the Unfolded Protein Response
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
The Intrinsic Apoptotic Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...